Hormones Inflammation and Thrombosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 100 participants.
Also called NCT01875185
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01875185
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01875185. Allocation not applicable; no masking; primary purpose diagnostic. Start 2012-12 (registry gives no type); primary completion 2013-11 (actual). Results posted on 2018-05-07.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hormones Inflammation and Thrombosis
- Acronym
- HIT2
- Condition
- Acute Coronary Syndrome
- Condition
- Thrombosis
- Intervention (Drug)
- Aspirin 81 mg
- Lead sponsor
- Johns Hopkins University
Record details
- Record id
cardio:ct-nct01875185- Content hash
bc423fc5f6c76aa07aeb0a21b3cf713688e2cb4643881bb3184ff9707ad3af0d